Skip to main content
Clinical Trials/NCT01618331
NCT01618331
Completed
Not Applicable

The Effect of Protein Supplementation Doing Regular Exercise in Patients With Facioscapulohumeral Muscular Dystrophy - a Blinded RCT Study

Grete Andersen, MD1 site in 1 country42 target enrollmentMarch 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Facioscapulohumeral Muscle Dystrophy
Sponsor
Grete Andersen, MD
Enrollment
42
Locations
1
Primary Endpoint
6MWT
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The hypotheses is that regular post exercise supplementation increase fitness and daily activity level in patients with Fascioscapulohumeral (FSH) muscular dystrophy.

All patients are tested before and after 12 weeks of cycle-ergometer exercise. Maximal oxygen consumption and 6MWT is used as primarily effect goals. Secondary effect goals are risk of falls and daily activity level.

Detailed Description

The purpose of this study is to investigate the response to protein-carbohydrate supplementation doing regular exercise in patients with FSHD. All patients are tested before and after 12 weeks of cycle-ergometer exercise. Maximal oxygen consumption and a functional 6 min walk test(6MWT) is used as primarily effect goals. Secondary effect goals are risk of falls and daily activity level. We measure manuel muscle strength, a balance test, a 5-time-up-and-down-chair-test, a 14 steps-stair-test, accelerometer measuring, daily activity level questionnaire and SP36. We use a blinded randomized controlled trail. The interventions are 12 weeks regular exercise and consumption of a post-exercise drink. The exercise consists of 30 session of 30 minutes moderate exercise on a cycle-ergometer. After each exercise session patients consume a protein or a non-caloric placebo drink.

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
October 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Grete Andersen, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Grete Andersen, MD

MD

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Verified FSHD
  • Age 18-65
  • Untrained. Less than two hours cardio-training each week the last 4 month.

Exclusion Criteria

  • Competitive disorders
  • Pregnant and breastfeeding
  • Unable to walk 200 m within 6 min.

Outcomes

Primary Outcomes

6MWT

Time Frame: up to Week 12

6 min walk test. Outcome in meter.

Maximal oxygen consumption test

Time Frame: up to Week 12

All participant are tested with a standardized maximal oxygen consumption test. Maximal oxygen uptake pr. minute pr. kg body (VO2max) weight and maximal work load (Wmax) is measured. The effect of intervention is found in different between groups in relative and absolute improvement in VO2max and Wmax.

Secondary Outcomes

  • Daily activity level(week: 0 and 12)
  • Risk of falls(week: 0 and 12)
  • Blood samples(week: 0, 4, 7, 10, 12)

Study Sites (1)

Loading locations...

Similar Trials